Atlas Trials

Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma

Clinical trial NCT06272656 · UNKNOWN

Trial details

NCT number
NCT06272656
Sponsor
Hebei Medical University Third Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2024-04-01
Primary completion
2025-04-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.